Stockscreener 앱 받기
3.78
1.61%
0.06
Lixte Biotechnology Holdings Inc 주식(LIXT)의 최신 뉴스
What analysts say about Lixte Biotechnology Holdings Inc. stockRapid profit acceleration - Jammu Links News
What analysts say about Lixte Biotechnology Holdings Inc. stock outlookFree Wealth-Building Investment Strategies - Newser
Lixte Biotechnology Regains Nasdaq Compliance After Fundraising - TipRanks
LIXTE Biotechnology Regains Nasdaq Compliance with $5M Financing - AInvest
What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock price move sharplyFree Consultation - beatles.ru
LIXTE Biotechnology's Compliance Win: A Turning Point for Clinical Gains and Stock Stability? - AInvest
LIXTE Biotechnology Holdings, Inc. Regains Nasdaq Compliance Following Successful Capital Raise - Quiver Quantitative
LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements - GlobeNewswire
LIXTE Secures $6.5M Funding, Maintains Nasdaq Listing While Advancing Cancer Drug Trials - Stock Titan
How Lixte Biotechnology Holdings Inc. Equity Warrant stock performs during market volatility - Newser
What makes Lixte Biotechnology Holdings Inc. stock price move sharplyFree Stock Selection - Newser
How Lixte Biotechnology Holdings Inc. stock performs during market volatilityBreakout Level Watch - Newser
Why Lixte Biotechnology Holdings Inc. Equity Warrant stock attracts strong analyst attentionFree Access to Community - Newser
Why Lixte Biotechnology Holdings Inc. stock attracts strong analyst attentionTop Performer Shortlist - Newser
LIXTE Biotechnology's LB100 Clinical Trials Receive Support from New Scientific Findings in Nature - AInvest
Lixte’s LB100 Clinical Trials Validated by Nature - TipRanks
LIXT 8-K: Nature Publication Validates Cancer Trial Mechanism | LIXTW SEC FilingForm 8-K - Stock Titan
Lixte Biotechnology Plunges 13.03% Amid Equity Financing - AInvest
Lixte Biotechnology Secures Strategic Capital to Accelerate Oncology Breakthroughs - AInvest
Lixte Biotechnology Closes $1.5M Direct Offering - The Globe and Mail
Spartan Capital Securities, LLC Serves as Placement Agent - GlobeNewswire
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $1.5 Million Registered Direct Offering - Yahoo Finance
New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials - The Manila Times
New Clinical Findings Published in Scientific Journal - GlobeNewswire
Nature Journal Validates Cancer Breakthrough in Ovarian and Colorectal Treatment Study | LIXTW Stock News - Stock Titan
Lixte Biotechnology (NASDAQ:LIXT) Shares Up 12.9% – Still a Buy? - Defense World
Lixte Biotechnology raises $1.5 million in registered direct offering By Investing.com - Investing.com South Africa
Broadway Financial Corporation shares rise 1.98% after-hours following Spartan Capital Securities' $5.0 million private placement for Lixte Biotechnology Holdings, Inc. - AInvest
Lixte Biotechnology raises $1.5 million in registered direct offering - Investing.com Australia
Lixte Biotechnology: Balancing Financial Constraints with Oncology Innovation - AInvest
Lixte Biotechnology Closes $1.5 Million Registered Direct Offering - MarketScreener
Lixte Biotechnology announces $5M equity financing; shares down - MSN
LIXT raises $1.5 m via direct offering; issues shares & warrants | LIXTW SEC FilingForm 8-K - Stock Titan
Lixte Biotechnology Holdings, Inc. Closes $1.5 Million Registered Direct Offering of Common Stock - Nasdaq
Lixte Biotechnology Holdings, Inc. Announces the Closing of $1.5 Million Registered Direct Offering - GlobeNewswire
Clinical-Stage Pharma Lixte Biotech Just Raised $1.5M at $1.54 Per ShareKey Details Revealed - Stock Titan
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, ... - Bluefield Daily Telegraph
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $5.0 Million Private Placement - TradingView
Why Apogee Therapeutics Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket - Benzinga
Why Did Lixte Biotechnology Plunge 13.78%? - AInvest
Biotech Stocks To Keep An Eye On – July 3rd - Defense World
Lixte Biotechnology Announces $5M Private Placement - The Globe and Mail
LIXT: Is a Growth Surge on the Horizon? - timothysykes.com
Lixte Biotechnology (NASDAQ:LIXTW) Stock Price Up 844.2% – What’s Next? - Defense World
Mogo Bets Big On Bitcoin, Inspira And Lixte Shine - Finimize
Lixte Biotechnology's $5M Private Placement: A Lifeline or a Liquidity Crisis? - AInvest
Lixte Biotechnology Holdings, Inc. Announces the Closing of $5.0 Million Private Placement Priced at the Market - GlobeNewswire
Biotech Lixte Raises $5M to Advance Clinical Programs: Key Details of Strategic Financing - Stock Titan
Lixte Biotechnology: Navigating Volatility Amid a $5M Financing Crossroads - AInvest
Lixte Biotechnology Holdings, Inc. Announces $5 Million Private Placement of Common Stock and Preferred Shares - Quiver Quantitative
0.64%
0.37%
자본화:
|
볼륨(24시간):